Quantitative Analysis of Polymer Additives with MALDI-TOF MS Using an Internal Standard Approach

2012 ◽  
Vol 23 (6) ◽  
pp. 1120-1125 ◽  
Author(s):  
Clemens Schwarzinger ◽  
Stefan Gabriel ◽  
Susanne Beißmann ◽  
Wolfgang Buchberger
Talanta ◽  
2019 ◽  
Vol 200 ◽  
pp. 236-241 ◽  
Author(s):  
Ling Ling ◽  
Chunsheng Xiao ◽  
Sheng Wang ◽  
Liming Guo ◽  
Xinhua Guo

2011 ◽  
Vol 60 (3) ◽  
pp. 359-365 ◽  
Author(s):  
M. Careri ◽  
L. Elviri ◽  
A. Lorenzi ◽  
A. Mangia ◽  
A. Penna ◽  
...  

2019 ◽  
Vol 26 (1) ◽  
pp. 55-62
Author(s):  
MeiHua Wan ◽  
Yichao Wang ◽  
Lingpeng Zhan ◽  
Jia Fan ◽  
Tony Y Hu

Background Serum C-peptide concentrations reflect insulin secretion and beta cell function and can be used to diagnose and distinguish type-1 and type-2 diabetes. C-peptide is a more accurate indicator of insulin status than direct insulin measurement for monitoring patients with diabetes. However, the current methods available for C-peptide quantification exhibit poor reproducibility, are costly, and require highly trained laboratory personnel. Here, we have developed and evaluated a matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-based assay to standardize C-peptide measurements, providing highly accurate and comparable results across testing systems and laboratories. Methods C-peptide from human serum was enriched using antibody-conjugated magnetic beads. The eluted isolates were further modified with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) to enhance the ionization of naturally acidic C-peptide. After desalting with ZipTips, the samples were subjected to MALDI-TOF MS analysis. Recombinant human C-peptide was used to develop the assay, and a heavy isotope labeled human C-peptide was used as an internal standard for quantification. Results The MALDI-TOF MS method was validated in accordance with the restrictions of the device, with a limit of quantitation of 25 pmol/L. A correlation between the MAL-DI-TOF MS assay and a reference method was conducted using patient samples. The resulting regression revealed good agreement. Conclusions A simple, high-throughput, cost effective and quantitative MALDI-TOF MS C-peptide assay has been successfully developed and validated in clinical serum samples.


2011 ◽  
Vol 412 (17-18) ◽  
pp. 1606-1615 ◽  
Author(s):  
Omar S. Barnaby ◽  
Ronald L. Cerny ◽  
William Clarke ◽  
David S. Hage

2015 ◽  
Vol 7 (9) ◽  
pp. 3967-3971 ◽  
Author(s):  
Nengxuan Ma ◽  
Wei Bian ◽  
Ruijin Li ◽  
Hong Geng ◽  
Jiangang Zhang ◽  
...  

In this work, we developed a novel quantitative analysis method for detecting nitropolycyclic aromatic hydrocarbons (nitro-PAHs) in PM2.5 samples with graphene as a matrix using MALDI-TOF MS.


2007 ◽  
Vol 53 (5) ◽  
pp. 852-858 ◽  
Author(s):  
Jakob Albrethsen

Abstract Background: Protein profiling with high-throughput sample preparation and MALDI-TOF MS analysis is a new potential tool for diagnosis of human diseases. However, analytical reproducibility is a significant challenge in MALDI protein profiling. This minireview summarizes studies of reproducibility of MALDI protein profiling and current approaches to improve its analytical performance. Methods: The PubMed database was searched using combinations of the following search terms: MALDI, SELDI, reproducibility, variation, precision, peak intensity, quantification, peptide, biomarkers, and proteomics. Acceptance criteria were detailed reports on the reproducibility with MALDI protein profiling and studies describing efforts to improve the analytical performance with this technology. Results: The reported intraexperiment CVs of the peak intensity vary highly between individual protein peaks, with the reported mean CV of the peak intensity varying among studies from 4% to 26%. There is additional interexperiment variation in peak intensity. Current approaches to improve the analytical performance of MALDI protein profiling include automated sample processing, extensive prefractionation strategies, immunocapture, prestructured target surfaces, standardized matrix (co)crystallization, improved MALDI-TOF MS instrument components, internal standard peptides, quality-control samples, replicate measurements, and algorithms for normalization and peak detection. Conclusions: Further evaluation and optimization of MALDI-TOF MS is recommended before use in routine analysis.


2011 ◽  
Vol 3 (10) ◽  
pp. 2360 ◽  
Author(s):  
Ajeet Singh ◽  
Venkateswarlu Panchagnula

Talanta ◽  
2021 ◽  
pp. 122792
Author(s):  
Xi Lin ◽  
Chunsheng Xiao ◽  
Ling Ling ◽  
Liming Guo ◽  
Xinhua Guo

2007 ◽  
Vol 177 (4S) ◽  
pp. 297-297
Author(s):  
Kristina Schwamborn ◽  
Rene Krieg ◽  
Ruth Knüchel-Clarke ◽  
Joachim Grosse ◽  
Gerhard Jakse

Sign in / Sign up

Export Citation Format

Share Document